Pharmaceutical Privately-held Swiss pharmaceutical group Helsinn has granted Chugai Pharma Marketing, a wholly-owned subsidiary of Chugai Pharmaceutical, itself a majority-owned unit of Swiss drug major Roche, exclusive commercialization rights to its innovative ghrelin receptor agonist, anamorelin, for the three major European pharma markets. 12 November 2013